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1726-4Outcome of mammography screening in TaiwanBreast cancer is the most common malignancy occurring in
women worldwide. An increasing number of investigators are
focusing on the prevention, diagnosis, treatment, and post-
treatment care of patients with breast cancer to improve
their longevity and quality of life. In addition to the genetic
studies contributing to advances in breast cancer prevention
and the progress of molecular biochemistry that has facilitated
the selection of systemic treatment, substantial efforts in
recent decades have led to the development of many effective
diagnostic modalities, especially in the early detection of
breast cancer.
A randomized trial using mammography-based screening
for the prevention of breast cancer was conducted in the 1960s
and was believed to be associated with a reduction in mor-
tality.1 The first nationwide population-based screening pro-
gram started in Finland in 1987.2 This program grouped
patients aged between 50 years and 59 years into cohorts born
in odd and even years and obtained the ratio of the detection
rate among those women invited to mammographic screening
with the rate among those women not invited. This ratio was
1:6. It was further observed that the prevalence of breast
cancer detected was 0.4%.2 Since then, a growing number of
studies have reported benefits of reduced mortality from early
detection with screening mammograms ranging from 21% to
32%.3,4 In these studies, the age of the invited group had a
greater range, including populations of women aged 45e50
years and 69e74 years.5 However, considerable discussion
and debate has challenged the long-term benefits of screening
mammograms in reducing mortality and, moreover, the extent
to which routine screening mammograms could foster over-
diagnosis and the unnecessary examination of patients.6
The incidence of breast cancer in Taiwan has increased
rapidly and it has become the most frequently diagnosed
cancer in women based on a report by the Health Promotion
Administration in the Ministry of Health and Welfare. In 2011,
the incidence rate was 64.3 per 100,000 after adjustment for
age (the median age was 53 years). The mortality rate is 15.99/
100,000, which represents 8.7% of all cancer deaths, with a
total of 10,056 patients diagnosed with invasive cancer (the 4th
highest percentage of all cancer deaths; the median age is 57
years). A total of 1852 women died from breast cancer.
Among these patients, the highest incidence of breast cancer
was in the group aged 40e49 years and 2157 women aged
<45 years 20.6 % were diagnosed with breast cancer. In thex.doi.org/10.1016/j.jcma.2014.08.003
901/Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical AssUSA, statistical data from the National Cancer Institute shows
that the median age of diagnosis is 61 years (most common
between aged 55 years and 64 years) with a stable trend of
incidence over the years 2002e2011 (about 12e14%); mor-
tality has fallen at an average of 1.9% each year. Therefore it
appears that breast cancer in Taiwan is typically encountered
at a younger age, with a higher and gradually increasing
incidence. The major mammographic screening trials in
Western populations have indicated a significant reduction in
breast cancer mortality from detecting tumors in an earlier,
less aggressive state. However, data on mammographic
screening among Asian women are limited. In Taiwan, breast
cancer screening has evolved in three stages from 1995 to
2004: two-stage breast cancer screening with a risk factor
questionnaire and mammography for those deemed at mod-
erate to high risk has the most favorable results. Thus to
promote breast cancer prevention, free mammographic
screening every 2 years for women aged 50e69 years has been
provided in Taiwan since 2004; it was extended to the 45e69
year age group in 2009 and extended further to the 40e44 year
age group for women at high risk since 2010.
We are pleased to see that a paper in this issue of the Journal
of the Chinese Medical Association has reported the current
status of mammographic screening in Taiwan.7 Although there
has been a significant increase in the workload of both the
women being screened and those performing the screening, the
quality of the screening is unaffected. It appears that the indi-
cators of recall rate, positive predictive values (PPV1), cancer
detection rate, incidence rate, and specificity reach the recom-
mended American College of Radiology levels, except for a
slightly lower sensitivity. However, with regard to the paper's
noted trend of an increased cancer detection rate and cancer
incidence rate after 2009 when younger women (45e49 years
old) were enrolled, some variables should be discussed. These
variables cannot be explained by the simple proposition that
mammographic screening was continuing to improve because
younger patients (who allegedly may be developing breast
cancer at an increased rate in Taiwan) were being screened. In
contrast with findings in the USA, the cancer incidence rates in
two age groups in Taiwan are both gradually increasing, espe-
cially in the past 10 years. In addition, the sensitivity in 2009
(79.6%) is lower than the average; whether this is a factor
influencing the change in cancer detection rate between 2009
and 2010 has not yet been determined.7 Furthermore, digitalociation. All rights reserved.
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most areas of Taiwan. With the popularity of the digital radi-
ography mammogram system in the screening institutes, this
may help improve the cancer detection rate with better reso-
lution and improved interpretation. Younger women are more
likely than older women to have dense breasts, so screening in
the younger age group may be accompanied by more false
positive results and unnecessary biopsy samples as a result of a
lower screening specificity.8e10 The use of a risk-based
screening approach may be a pragmatic solution to this prob-
lem and may facilitate the balancing of both the benefits and the
harms of mammographic screening, as suggested by the Health
Promotion Administration in the Ministry of Health and Wel-
fare. However, clinicians have the responsibility in their prac-
tices of discussingwith their female patients between the ages of
40 years and 49 years the benefits, limitations, and even the
potential harm of undergoing screening mammography.
In this issue of the Journal of the Chinese Medical Asso-
ciation, in the paper entitled “The outcome of a quality-
controlled mammography screening program: experience
from a population-based study in Taiwan”, the authors should
provide a more extensive explanation as to why mammog-
raphy is beneficial for cancer detection in younger women
with an even higher breast density.7
In Taiwan, nationwide free mammographic screening for
women between the ages of 40 years and 69 years is beneficial
in the early detection of breast cancer. This paper provides us
with more recent information about the effectiveness of
screening mammography in breast cancer detection. Although
it is a fact that younger women have a higher incidence of
breast cancer in Taiwan compared with comparably aged
women in Western countries, results from randomized trials of
population-based breast screening using mammography have
not shown a statistically significant benefit of breast screening
in women younger than 50 years of age. More information
needs to be collected about the trend of breast cancers after
2009 when the younger age group was enrolled in the breast
screening program. The result of this population-based mam-
mographic breast screening program could provide guidance
for a systematic approach to breast cancer detection in Taiwan.
Furthermore, the results of a pilot study of breast cancer
screening by sonography in women aged 40e69 years may
more effectively determine the most appropriate nationwide
breast cancer screening program in Taiwan.
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